The store will not work correctly when cookies are disabled.
3-(5-Cyclohexyl-1H-imidazol-2-yl)-pyridine
ID: ALA332381
PubChem CID: 44345719
Max Phase: Preclinical
Molecular Formula: C14H17N3
Molecular Weight: 227.31
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: c1cncc(-c2nc(C3CCCCC3)c[nH]2)c1
Standard InChI: InChI=1S/C14H17N3/c1-2-5-11(6-3-1)13-10-16-14(17-13)12-7-4-8-15-9-12/h4,7-11H,1-3,5-6H2,(H,16,17)
Standard InChI Key: HSNIPLAHMYNOOH-UHFFFAOYSA-N
Molfile:
RDKit 2D
17 19 0 0 0 0 0 0 0 0999 V2000
3.5875 -3.3875 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.0875 -2.7292 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
3.1167 -4.0667 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
2.3042 -3.0042 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.3292 -3.8292 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.4125 -3.3667 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.6292 -2.6292 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
1.6292 -2.5417 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.8042 -2.6417 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.8417 -4.0667 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.0625 -3.3292 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.6917 -1.7250 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.8917 -2.9000 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.6667 -4.0542 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.2125 -2.4292 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.0250 -1.2542 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.2792 -1.6125 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2 1 2 0
3 1 1 0
4 2 1 0
5 3 1 0
6 1 1 0
7 9 2 0
8 4 1 0
9 6 1 0
10 6 2 0
11 14 2 0
12 8 1 0
13 8 1 0
14 10 1 0
15 13 1 0
16 12 1 0
17 15 1 0
5 4 2 0
11 7 1 0
17 16 1 0
M END
Associated Targets(Human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 227.31 | Molecular Weight (Monoisotopic): 227.1422 | AlogP: 3.52 | #Rotatable Bonds: 2 |
Polar Surface Area: 41.57 | Molecular Species: NEUTRAL | HBA: 2 | HBD: 1 |
#RO5 Violations: ┄ | HBA (Lipinski): 3 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: 13.45 | CX Basic pKa: 5.80 | CX LogP: 2.91 | CX LogD: 2.90 |
Aromatic Rings: 2 | Heavy Atoms: 17 | QED Weighted: 0.85 | Np Likeness Score: -0.83 |
References
1. Elliott RL, Oliver RM, LaFlamme JA, Gillaspy ML, Hammond M, Hank RF, Maurer TS, Baker DL, DaSilva-Jardine PA, Stevenson RW, Mack CM, Cassella JV.. (2003) Structure-activity relationship studies on 2-heteroaryl-4-arylimidazoles NPY5 receptor antagonists., 13 (20): [PMID:14505677] [10.1016/s0960-894x(03)00747-9] |